Cargando…
Changes in neurophysiologic markers of visual processing following beneficial anti-VEGF treatment in macular degeneration
PURPOSE: Antivascular endothelial growth factor (VEGF) agents have been shown to improve visual acuity and prevent vision loss in exudative age-related macular degeneration. As the vision improves relatively quickly in response to intravitreal injections, we wanted to know whether this improvement i...
Autores principales: | Vottonen, Pasi, Kaarniranta, Kai, Pääkkönen, Ari, Tarkka, Ina M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589120/ https://www.ncbi.nlm.nih.gov/pubmed/23467427 http://dx.doi.org/10.2147/OPTH.S40427 |
Ejemplares similares
-
Visual processing in patients with age-related macular degeneration performing a face detection test
por: Vottonen, Pasi, et al.
Publicado: (2017) -
Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
por: Korva-Gurung, Ida, et al.
Publicado: (2023) -
Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐model
por: Pesonen, Mari, et al.
Publicado: (2021) -
Application and mechanism of anti-VEGF drugs in age-related macular degeneration
por: Song, Dawei, et al.
Publicado: (2022) -
Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)